Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury

被引:63
作者
Nakamura, Yoshihiko [1 ]
Ishikura, Hiroyasu [1 ]
Nishida, Takeshi [1 ]
Kawano, Yasumasa [1 ]
Yuge, Rie [1 ]
Ichiki, Reiko [1 ]
Murai, Akira [1 ]
机构
[1] Fukuoka Univ, Fac Med, Dept Emergency & Crit Care Med, Jonan Ku, Fukuoka 8140180, Japan
来源
BMC ANESTHESIOLOGY | 2014年 / 14卷
关键词
Presepsin; Acute kidney injury; RIFLE criteria; Sepsis; Diagnosis; ACUTE-RENAL-FAILURE; INFLAMMATORY RESPONSE; QUALITY; THERAPY; SIRS; CARE;
D O I
10.1186/1471-2253-14-88
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Presepsin is useful for differentiating sepsis from non-infection related systemic inflammatory response syndrome. However, there are no studies investigating the usefulness of presepsin in diagnosing sepsis involving patients with acute kidney injury (AKI). The purpose of this study is to determine levels of blood presepsin in patients with or without sepsis and among non-AKI patients or patients with different degrees of AKI severity. Methods: This is a single center retrospective study. 247 patients admitted to the ICU between June 2010 and October 2012 were analyzed for their presepsin levels. We classified the patients into non-AKI and AKI according to the RIFLE (Risk, Injury, Failure, and Loss of kidney function and End-stage kidney disease or simply Loss and ESKD) criteria. We then sub-classified the patients in each group into either non-sepsis or sepsis sub-group and analyzed the accuracy of diagnosing sepsis based on their levels of presepsin. Results: The number of patients for each group was: non-AKI, 112; under AKI: Risk, 50; Injury, 36; Failure, 42; Loss and ESKD, 7. The levels of presepsin in sepsis groups were significantly higher than that in the non-sepsis group among the non-AKI, Risk and Injury patients (p < 0.0001, p < 0.01, p < 0.01, respectively). However, no significant difference in the level of presepsin between non-sepsis and sepsis groups among patients with Failure. In the receiver operating characteristic (ROC) analysis, the area under the curve (AUC) was 0.784 in the non-AKI group and 0.698 in the AKI comprising Risk, Injury and Failure groups. AUC value for non-AKI was not significantly different from that of AKI (p = 0.200). When 670 pg/mL was used as the cutoff value for presepsin, sensitivity and specificity were 70.3% and 81.3%, respectively. When 864 pg/mL was used as the cutoff value for presepsin, sensitivity and specificity were 71.4% and 63.8%, respectively. Conclusions: Presepsin level can be a reliable indicator of sepsis not only among non-AKI patients but also patients with less severe forms of AKI. However, it may not be a reliable indicator of sepsis in patients with a more advanced form of AKI.
引用
收藏
页数:7
相关论文
共 23 条
  • [11] Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
    Kumar, Arland
    Roberts, Daniel
    Wood, Kenneth E.
    Light, Bruce
    Parrillo, Joseph E.
    Sharma, Satendra
    Suppes, Robert
    Feinstein, Daniel
    Zanotti, Sergio
    Taiberg, Leo
    Gurka, David
    Kumar, Aseem
    Cheang, Mary
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (06) : 1589 - 1596
  • [12] Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST
    Kurihara, Takashi
    Yanagida, Atsushi
    Yokoi, Hiroyuki
    Koyata, Atsushi
    Matsuya, Takeshi
    Ogawa, Junichi
    Okamura, Yoshikazu
    Miyamoto, Daishi
    [J]. ANALYTICAL BIOCHEMISTRY, 2008, 375 (01) : 144 - 146
  • [13] Revised Equations for Estimated GFR From Serum Creatinine in Japan
    Matsuo, Seiichi
    Imai, Enyu
    Horio, Masaru
    Yasuda, Yoshinari
    Tomita, Kimio
    Nitta, Kosaku
    Yamagata, Kunihiro
    Tomino, Yasuhiko
    Yokoyama, Hitoshi
    Hishida, Akira
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (06) : 982 - 992
  • [14] Acute kidney injury: what's the prognosis?
    Murugan, Raghavan
    Kellum, John A.
    [J]. NATURE REVIEWS NEPHROLOGY, 2011, 7 (04) : 209 - 217
  • [15] Naito K, 2011, United States Patent, Patent No. [A1:US 0086381, 0086381]
  • [16] Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis
    Oda, S
    Hirasawa, H
    Shiga, H
    Nakanishi, K
    Matsuda, KI
    Nakamua, M
    [J]. CYTOKINE, 2005, 29 (04) : 169 - 175
  • [17] Development of a point-of-care assay system for measurement of presepsin (sCD14-ST)
    Okamura, Yoshikazu
    Yokoi, Hiroyuki
    [J]. CLINICA CHIMICA ACTA, 2011, 412 (23-24) : 2157 - 2161
  • [18] THE NATURAL-HISTORY OF THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) - A PROSPECTIVE-STUDY
    RANGELFRAUSTO, MS
    PITTET, D
    COSTIGAN, M
    HWANG, T
    DAVIS, CS
    WENZEL, RP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (02): : 117 - 123
  • [19] Practice patterns in the management of acute renal failure in the critically ill patient: an international survey
    Ricci, Z
    Ronco, C
    D'amico, G
    De Felice, R
    Rossi, S
    Bolgan, I
    Bonello, M
    Zamperetti, N
    Petras, D
    Salvatori, G
    Dan, M
    Piccinni, P
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (03) : 690 - 696
  • [20] Early goal-directed therapy in the treatment of severe sepsis and septic shock.
    Rivers, E
    Nguyen, B
    Havstad, S
    Ressler, J
    Muzzin, A
    Knoblich, B
    Peterson, E
    Tomlanovich, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) : 1368 - 1377